Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the OptejetĀ® delivery system for use both in connection with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications.
View Top Employees from Eyenovia, Inc.Website | http://eyenovia.com |
Employees | 47 (47 on RocketReach) |
Founded | 2014 |
Address | 295 Madison Ave Suite 2400, New York, New York 10017, US |
Industry | Pharmaceuticals, Ophthalmology |
Looking for a particular Eyenovia, Inc. employee's phone or email?
Michael Rowe is the CEO of Eyenovia, Inc..
47 people are employed at Eyenovia, Inc..
Eyenovia, Inc. is based in New York, New York.